Context: Little information is available on the steroid hormone profiles in obese children and their changes after weight loss.
O besity is a complex condition associated with changes in steroid hormone synthesis: it has been documented that cortisol levels are moderately increased in obese children (1) and adults (2) (3) (4) . Furthermore, T concentrations are increased in obese children (5) and obese women (6) . In contrast, obese men have demonstrated decreased androgen levels (5, 7) .
Interestingly, obese children with increased cortisol levels and obese adolescent females and women with increased androgens as well as obese men with low T levels are more prone to metabolic disturbances such as insulin resistance, type 2 diabetes mellitus, lipid abnormalities, and hypertension and may therefore be at particular risk of developing atherosclerotic complications (1, 5, 8, 9) . On the other hand, there is increasing evidence that T treatment improves insulin sensitivity and lipid profiles in obese men (10) . Furthermore, a high androgenic activity is discussed to be associated with precocious puberty, premature adrenarche, and accelerated bone age with relatively tall stature in children (11) . Additionally, increased androgens have even been postulated to cause obesity in childhood (11) . To understand these complex relationships between steroid hormones, obesity, and its comorbidities, it would be ideal to study the differential regulation of steroid hormone concentrations in obese children, which are naïve to drugs and other comorbidities.
The differential regulation of steroid hormone concentrations encompassing glucocorticoids, mineralocorticoids, androgens, and their specific precursors in obesity is largely unknown. In particular, little and controversial information is available on steroid hormones in obese children. Some investigators stated that hyperandrogenemia occurs only after menarche (12) . One study reported lower T levels in male and female obese prepubertal children as compared with normal-weight children (13) . Other studies revealed similar T concentrations in obese and normal-weight prepubertal boys and girls but increased dehydroepiandrosterone sulfate (DHEAS) levels in obese prepubertal children (14, 15) .
Because only sparse and contradicting data exist on the different classes of steroid hormones in prepubertal obese children, we analyzed a comprehensive serum profile of 12 steroid hormones, androgens, mineralocorticoids, glucocorticoids, and their precursors using a liquid chromatography-tandem mass spectrometry (LC-MS/MS) steroid profiling method (16) . We hypothesized that androgen and glucocorticoid concentrations are increased in obese prepubertal children as compared with age-matched normal-weight prepubertal children and decreased in substantial weight loss, suggesting that changes of steroids in childhood obesity are a consequence and not a cause of obesity.
Materials and Methods

Subjects
Written informed consent was obtained from all parents of the participants prior to inclusion of the study. The study was approved by the local Ethics Committee of the University of Witten/Herdecke in Germany.
We examined 40 obese prepubertal Caucasian children [median age 8.8 (interquartile range [IQR]) 6.9 -9.8 years, 48% female, median body mass index (BMI) 24.9 (IQR 22.3-26.8) kg/m 2 ] and 40 normal-weight prepubertal children matched for age and gender. All boys were stages G1 and P1 and all girls were stages B1 and P1 according to the pubertal stages of Tanner and Whitehouse.
The 40 prepubertal obese children were recruited randomly from our obesity cohort (17) including 20 obese children with substantial weight loss and 20 obese children without weight loss. Substantial reduction of overweight was defined by a decrease in SDS score of BMI (BMI-SDS) of 0.5 or greater ,and no reduction of overweight was defined by a decrease in BMI-SDS less than 0.1. This classification was used because in a reduction of less than 0.5 BMI-SDS, no improvement of insulin resistance and cardiovascular risk factors could be measured and hormones like leptin or cortisol did not tend to normalize below this cutoff point in obese German children (1, 18, 19) . Children with changes of BMI-SDS between 0.1 and less than 0.5 were not included in this study.
All 40 obese children participated in the lifestyle intervention, Obeldicks, which has been described in detail elsewhere (20) . Briefly, this outpatient intervention program for obese children is based on physical exercise, nutrition education, and behavior therapy including the individual psychological care of the child and his or her family. The nutritional course is based on a fat-and sugar-reduced diet as compared with the everyday nutrition of German children.
None of the children in the current study suffered from endocrine disorders, premature adrenarche, or syndromal obesity or received any drug. None of the obese children entered into puberty during the study period.
Measurements
We analyzed BMI, blood pressure (BP), and fasting serum steroid hormones (progesterone, 17-hydroxyprogesterone, 11-deoxycorticosterone, corticosterone, 11-deoxycortisol, cortisol, cortisone, androstendione, T, dihydrotestosterone, and DHEAS) in 40 obese and 40 normal-weight children. Aldosterone was determined only in the 40 obese patients with and without weight loss but not in normal-weight children.
These hormones, body fat based on skinfold thickness, waist circumference, and the insulin resistance index of homeostasis model assessment (HOMA) were determined in the 40 obese children at baseline and after the 1-year lifestyle intervention Obeldicks.
Height was measured to the nearest centimeter using a rigid stadiometer. Weight was measured unclothed to the nearest 0.1 kg using a calibrated balance scale. BMI was calculated as weight in kilograms divided by the square of height in meters. The degree of overweight was quantified using Cole's least mean square method, which normalized the BMI skewed distribution and expressed BMI as a SD score (BMI-SDS) (21) . Reference data for German children were used (22) . All of the children in the study were obese according to the definition of the International Obesity Task Force (23) . Waist circumference was measured halfway between lower rib and iliac crest.
BP was measured using a validated protocol (24) . Systolic and diastolic BP were measured at the right arm twice after a 10minute rest in the supine position by using a calibrated sphygmomanometer and averaged. The cuff size was based on the length and circumference of the upper arm and was as large as possible without having the elbow skin crease obstructing the stethoscope (24) . The intra-and interoperator variability was less than 5% for systolic and diastolic BP.
Triceps and subscapularis skinfold thickness was measured twice using a caliper and averaged to calculate the percentage of body fat using a skinfold thickness equation with the following formulas (25): for boys, body fat percentage ϭ 0.783 ϫ (subscapularis skinfold thickness ϩ triceps skinfold thickness in millimeters) ϩ 1.6; for girls, body fat percentage ϭ 0.546 ϫ (subscapularis skinfold thickness ϩ triceps skinfold thickness in millimeters) ϩ 9.7.
Blood sampling was performed in the fasting state at 8:00 AM. After clotting, blood samples were centrifuged for 10 minutes at 8000 rpm. Serum was stored at Ϫ81°C for later determination of steroid hormones and insulin. All samples were thawed only once. Insulin concentrations were measured by microparticle enhanced immunometric assay (MEIA; Abbott, Wiesbaden, Germany). Glucose levels were determined by colorimetric test using a Vitros analyzer (Ortho Clinical Diagnostics, Neckargmuend, Germany). Except for DHEAS, all steroid hormones were determined in a parallel assay by LC-MS/MS as previously described (16) . In brief, 0.1 mL serum was extracted using an Oasis SPE system (Waters, Milford, Massachusetts). The steroid measurements were carried out using an UPLC Quattro Premier/Xe system (Waters). DHEAS was determined in a separate LC-MS/MS assay using the same UPLC Quattro Premier/Xe system. Intra-and interassay coefficients of variation were less than 5% for all measurements.
To interpret enzyme activities in the steroid metabolism, we calculated ratios between precursor steroids and their resulting downstream products in the steroid pathway.
HOMA was used to detect the degree of insulin resistance using the formula: resistance (HOMA) ϭ [insulin (milliunits per liter) ϫ glucose (millimoles per liter)]/22.5 (26) .
Statistics
Statistical analyses were performed using the Winstat software package (R. Fitch Software, Bad Krozingen, Germany). Normal distribution was tested by the Kolmogorov-Smirnov test. Changes of steroid hormones in the 1-year follow-up were correlated to changes of insulin and changes of BP by partial regression analyses adjusted to changes of BMI-SDS. To compare variables at baseline or in the course of 1 year, a Fisher exact test and a Student's t test for paired and unpaired observations, Wilcoxon and Mann-Whitney U test were used as appropriate. A P Ͻ .01 was considered as significant to account for multiple testing. Data were presented as median and IQR.
Results
The prepubertal obese children demonstrated significantly increased concentrations of the glucocorticoids 11deoxycortisol, cortisol, and cortisone compared with normal-weight children ( Table 1) . Although the mineralocorticoid precursor corticosterone was significantly increased in obese children, its direct precursor 11-deoxycorticosterone tended to show lower levels compared with the normal-weight group (Table 1) . Among the androgens, androstenedione, T, and DHEAS were all significantly increased in the obese children, whereas dihydrotestosterone did not differ significantly. Progesterone and 17-hydroxyprogesterone also did not differ significantly between the 2 groups (Table 1) . Substantial weight loss in 20 obese children [in median Ϫ0.52 (IQR Ϫ0.84 to Ϫ0.50) BMI-SDS] was associated with significant decreases of body fat, BP, insulin, and HOMA ( Table 2 ). The 3 different classes of steroid hormones showed distinct patterns of changes after weight loss. Among the glucocorticoids, cortisol and cortisone levels decreased significantly. Also, 11-deoxycortisol decreased but this change was not statistically significant ( Table 2 ). The mineralocorticoids, 11-deoxycorticosterone and aldosterone, did not change significantly. How-ever, the corticosterone levels fell significantly ( Table 2 ). In the androgen group of steroid hormones, androstenedione and T levels dropped significantly after the weight loss ( Table 2 ). In contrast, the elevated DHEAS remained at its high level during the 1-year follow-up period of our study. Dihydrotestosterone, progesterone, and 17-hydroxyprogesterone did not change significantly after the weight loss (Table 2 ).
In the obese children without substantial weight loss [BMI-SDS in median ϩ0.03 (IQR Ϫ0.09 to ϩ0.10)], neither significant changes of body fat, insulin, HOMA, and BP nor steroid hormone concentrations were observed. Waist circumference tended to increase in obese children without substantial weight loss in contrast to obese children with substantial weight loss ( Table 2 ). The obese children with and without substantial weight loss did not differ at baseline con- cerning their weight status (BMI), body fat, waist circumference, HOMA, or steroid hormones ( Table 2 ). The ratios between cortisol and cortisone did not differ significantly (P ϭ .087) between normal-weight [4.3 (IQR 3.3-5.5)] and obese children [3.3 (IQR 2.8 -4.9)]. The ratios between precursor steroids and their resulting downstream products in the steroid pathway did not change significantly in the 20 obese children with and without substantial weight loss and did not differ between the children with and without substantial weight loss at baseline or in follow-up (Table 3 ).
In the 1-year follow-up, changes of waist circumference were significantly positively correlated with changes of T (r ϭ 0.44, P ϭ .002) in partial regression analyses adjusted to changes of BMI-SDS but not with changes of any other steroid hormone. Changes of insulin were correlated significantly positively with changes of cortisol (r ϭ 0.35, P ϭ .014), cortisone (r ϭ 0.43, P ϭ .003), and dihydrotestosterone (r ϭ 0.34, P ϭ .018) in partial regression analyses adjusted to changes of BMI-SDS but not with changes of any other steroid hormone. Changes of HOMA were correlated significantly positively with changes of cortisol (r ϭ 0.38, P ϭ .010), cortisone (r ϭ 0.43, P ϭ .004), and dihydrotestosterone (r ϭ 0.42, P ϭ .005) in partial regression analyses adjusted to changes of BMI-SDS but not with changes of any other steroid hormone. The changes of systolic BP did not significantly correlated with any steroid hormone in partial regression analyses adjusted to changes of BMI-SDS. The changes of diastolic BP were correlated significantly positively with changes of corticosterone (r ϭ 0.50, P Ͻ .001) and 11-desoxycortisol (r ϭ 0.44, P ϭ .003) in partial regression analyses adjusted to changes of BMI-SDS but not with changes of any other steroid hormone.
Discussion
To the best of our knowledge, this is the first study analyzing the longitudinal relationships of a comprehensive steroid profile encompassing glucocorticoids, mineralocorticoids and androgens, several precursors of the active steroids, insulin, the insulin resistance index HOMA, and BP in obese prepubertal children participating in a lifestyle intervention.
Compared with normal-weight children of the same age and gender, obese prepubertal children demonstrated significantly increased androgens and glucocorticoids and significantly increased levels of the mineralocorticoid precursor corticosterone. Normalization of concentrations in response to weight loss as seen for the glucocorticoids and corticosterone as well as for androstenedione and T indicate that their elevation in obese prepubertal children is rather the consequence than the cause of obesity. However, the persistently elevated DHEAS after weight loss is in marked contrast to these findings. It indicates an irreversible maturation of the zona reticularis and the formation of DHEAS in the prepubertal obese children.
The reversibility of the elevation of glucocorticoids after weight loss may point toward a reversible activation of the hypothalamo-pituitary-adrenal (HPA) axis. In women, the increased production of ACTH has been described in obesity (27) . Moreover, a slightly increased sensitivity of the HPA axis has been reported in obese adults (28) . In obese rats, in vivo and in vitro enhanced adrenocortical response to ACTH stimulation, an in vitro adrenal fasciculata-reticularis cell hypersensitivity to ACTH stimulus, hyperplasia of their adrenal zona fasciculata cells, and adrenal fasciculata-reticularis cell refractoriness to the inhibitory effect of leptin on ACTH-stimulated glucocorticoid production due, at least in part, to decreased adrenal leptin receptor expression have been reported (29) . However, because HOMA was related to glucocorticoids in our study, insulin resistance may also contribute to higher glucocorticoid levels, for example influencing the levels of peripheral enzymes (30) .
Evidence has been presented that activity of 11␤-hydroxysteroid dehydrogenase type 1 (11␤-HSD1) converts hormonally inactive cortisone to active cortisol (30, 31) . This process may be of particular relevance in central obesity due to 11␤-HSD1 activity in the omental fat tissue (32) . However, Wiegand et al (33) reported that 11␤-HSD1 activity is reduced in obese boys. In our study, we did not find a significant relationship between waist circumference and cortisol or cortisone. Additionally, we neither found significant differences of cortisol to cortisone ratios between normal-weight children and obese children nor significant changes of this ratio after weight loss according to another study of obese prepubertal children (34) . On the other hand, the higher glucocorticoid levels in obesity may also be cause of insulin resistance in obese prepubertal children. Our study protocol does not allow differentiating whether insulin resistance follows increased glucocorticoids in obesity or whether increased glucocorticoids are a consequence of insulin resistance.
The predominant feature of the mineralocorticoid pattern was the significant elevation of corticosterone in the obese prepubertal children vs the normal-weight children and its significant drop to about the range seen in normalweight children after weight loss. In contrast, 11-deoxycorticosterone and aldosterone showed only marginal changes after weight loss. This hormone pattern argues against a relevant activation of the renin-angiotensin pathway in obesity. In contrast, our data support an ACTHmediated activation of the CYP11B1 enzymatic step in the zona fasciculata giving rise to increased corticosterone formation. Our additional observation that changes of the diastolic BP were correlated with corticosterone levels supports that higher concentrations of these mineralocorticoids in prepubertal obese children may contribute to their elevated BP.
There are different potential mechanisms that may act alone or in concert causing the elevated concentrations of the androgens DHEAS, androstenedione, and T in the prepubertal obese children. In addition to an increased central activation of the HPA axis, CRH has been suggested to increase adrenal androgen secretion directly in children (35) . In addition, leptin may also act at the level of adrenal steroid biosynthesis because it has a documented dosedependent role to promote the formation of adrenal androgens by stimulating 17,20-lyase activity of CYP17 (36) . Therefore, leptin secreted by the adipose tissue may be an important functional link between obesity and in- creased androgens in prepubertal obese children. Another important enzymatic step for androgen formation is the ⌬5 to ⌬4 conversion of dehydroepiandrosterone to androstenedione. It has been shown that 3␤-hydroxysteroid dehydrogenase expression can be enhanced via an insulin receptor substrate-1-and -2-dependent pathway in different tissue types (37) . Therefore, the increased insulin concentrations in obesity as also shown in our present study could activate this enzymatic step in the adrenals and in the periphery, respectively, thus contributing to the observed increased prepubertal androstenedione formation. After puberty, insulin has additional documented roles in gonadal androgen formation (38) . One of the most intriguing findings of our long-term study is the fact that the elevated DHEAS in obesity did not normalize after weight loss as compared with all other steroids. In contrast, short-term studies in children and adolescents revealed decreasing DHEAS concentrations in weight loss (14, 39) . Our data support a premature, enhanced, and irreversible differentiation of the zona reticularis in the prepubertal obese children. Adrenal androgen production normally starts to increase before gonadal production at the age of 6 -8 years (40) . Once the developmental path of adrenarche has been initiated, it continues irreversibly as reflected by the increasing DHEAS concentrations during the study period, even after successful weight loss. We cannot decipher, however, whether obesity has been the first event that has only secondarily initiated preterm adrenarche or whether preterm adrenarche has actually been the first hit promoting development of obesity as the secondary event, which has also been suggested by others (11, 14) .
Strengths and limitations of the study
The strengths of this study are its longitudinal design; the analyses of a comprehensive profile of glucocorticoids, mineralocorticoids, and androgens by a state-of-the-art LC-MS/MS multisteroid profiling method (16) ; and the study of a homogenous cohort of prepubertal obese chil-dren naive to drugs. However, our study presents some potential limitations. First, BMI percentiles were used to classify overweight. Although BMI is a good measure for overweight, one needs to be aware of its limitations as an indirect measurement of fat mass. Second, androgens are bound to SHBG, the concentrations of which are influenced by many factors. SHBG is decreased in obese children, regardless of pubertal stage or gender (5, 13) . Therefore, a measurement of increased androgens in obese children points to an increased androgen activity. Third, androgen concentrations correlate with fat distribution (39) . This probably explains the different findings concerning androgens in childhood obesity. However, only T concentrations were associated with waist circumference in our study. Fourth, our study sample was too small to study gender differences on the changes of steroids. Finally, weight loss may be too small to measure effects on DHEAS levels. On the other hand, a reduction of the BMI-SDS of 0.5 or greater, as achieved in our children with substantial weight loss, is reported to normalize many hormonal and metabolic changes in childhood obesity like insulin sensitivity, the cardiovascular risk factor profile, hormones, and adipocytokines (1, 18, 19) .
In summary, moderately increased steroid hormones were found in obese prepubertal children. Weight loss induced a decrease of most of these steroid hormones pointing to a reversible increase of these hormones in obesity. In contrast, DHEAS remained constantly elevated after weight loss pointing to an irreversible increased production in the adrenals in prepubertal obese children. Based on the profiles of steroids, the adrenals are likely to be the major source for the elevated hormone concentration. However, relevant biosynthesis may also occur in peripheral tissues, which seems particularly relevant for androstendione and T. There is still a great need for further research to understand the pathogenesis of age-dependent alterations of steroid hormones in obesity and the contributions of different tissues therein. 
